Cover Image
市場調查報告書

全球醫療、外科用密封膠,黏劑,止血劑市場:主要地區 (南北美洲,歐洲,亞太地區,其他) 的現有、新興產品,技術,市場

Worldwide Markets for Medical and Surgical Sealants, Glues and Hemostats 2015-2022: Established and Emerging Products, Technologies and Markets in the Americas, Europe, Asia/Pacific and Rest of World

出版商 MedMarket Diligence, LLC 商品編碼 358723
出版日期 內容資訊 英文 310 Pages; 144 Exhibits; 104 Company Profiles
商品交期: 最快1-2個工作天內
價格
Back to Top
全球醫療、外科用密封膠,黏劑,止血劑市場:主要地區 (南北美洲,歐洲,亞太地區,其他) 的現有、新興產品,技術,市場 Worldwide Markets for Medical and Surgical Sealants, Glues and Hemostats 2015-2022: Established and Emerging Products, Technologies and Markets in the Americas, Europe, Asia/Pacific and Rest of World
出版日期: 2016年07月31日 內容資訊: 英文 310 Pages; 144 Exhibits; 104 Company Profiles
簡介

本報告提供全球醫療、外科用密封膠,黏劑,止血劑市場相關調查分析,目前臨床開發,技術開發,市場規模與預測,競爭企業的市場佔有率,65家公司簡介,現在、未來市場機會的評估等系統性資訊。

第1章 臨床性必要性、處理數量、治療數量

  • 組織修復的解剖學和生理學
  • 皮膚
  • 內部組織和器官
  • 創傷的分類與類型
    • 分類:各形態、重症度
    • 分類:各原因
    • 手術創傷
  • 處理數量
    • 一般外科
    • 心血管
    • 中樞神經系統
    • 整形外科
    • 泌尿科
    • 皮膚科
  • 醫療用密封膠、黏劑、止血產品定義和作用
  • 天然物、生物製藥
  • 產品:各原料
  • 合成、半合成產品
  • 止血劑

第2章 科學、技術、開發、臨床與規定上的課題

  • 組織的治癒
  • 開發中的產品
  • 開發時間軸
  • 成本效益
  • 法規上的課題

第3章 產品、技術、預測的機會

  • 概要
  • 密封膠,纖維蛋白,其他密封膠產品
  • 高強度的醫療用黏劑
  • 止血劑
  • 競爭情形

第4章 創傷密封膠、黏劑、止血劑市場:全球、各地區分析

  • 全球創傷密封膠、黏劑、止血劑市場
  • 美國
  • EU
  • 亞太地區
  • 其他

第5章 企業簡介

  • 3DM, Inc. (3D-Matrix, Ltd.)
  • Actamax Surgical Materials, LLC
  • Adhesys Medical GmbH
  • Adhezion Biomedical, LLC
  • Advanced Medical Solutions Group plc/Medlogic Global
  • Arch Therapeutics, Inc.
  • Baxter International, Inc.
  • B. Braun Melsungen AG
  • Biomedica Management Corporation
  • Biom'Up SAS
  • C.R. Bard (Bard Medical, Davol)
  • Cardinal Health
  • Cellphire, Inc.
  • Celox Medical
  • Chemence Medical
  • Cohera Medical, Inc.
  • Core Scientific Creations, Ltd.
  • Covalon Technologies, Ltd.
  • Covidien Ltd.
  • CryoLife Inc.
  • CSL Behring
  • CuraMedical BV
  • Endomedix, Inc.
  • Entegrion, Inc.
  • Gecko Biomedical
  • Gelita Medical AG
  • GluStitch, Inc.
  • Grifols International, S.A.
  • Hemostasis, LLC
  • HyperBranch Medical Technology, Inc.
  • InnoTherapy, Inc.
  • Innovasa Corporation
  • Integra Lifesciences Corporation
  • Johnson & Johnson (Ethicon, Inc., Ethicon Endo-Surgery, Inc.)
  • Kuros Biosciences, Ltd.
  • LifeBond Ltd.
  • Mallinckrodt
  • Marine Polymer Technologies
  • MedTrade Products, Ltd.
  • Meyer-Haake, GmbH
  • Ocular Therapeutix, Inc.
  • OptMed, Inc.
  • Pfizer Inc.
  • Polyganics
  • Pulmonx
  • Sanofi
  • 三洋化成工業
  • Scion BioMedical, Inc.
  • Sealantis, Ltd.
  • Sea Run Holdings, Inc.
  • Skinstitch Corporation
  • Starch Medical, Inc.
  • Stryker
  • St. Teresa Medical, Inc.
  • Surgical Specialties Corporation
  • 武田藥品工業
  • The Medicines Company
  • Thrombotargets Corp.
  • Tissuemed Ltd.
  • Tricol Biomedical, Inc.
  • Vascular Solutions
  • Xcede Technologies (Dynasil)
  • Z-Medica Corporation

附錄:企業名錄

目錄
Product Code: S290

This report assesses the global current and forecast market for products used in sealing, glue- or adhesive-mediated closure, and hemostasis of medical and surgical wounds. The report details the patient populations, their incidence and prevalence globally and (in select instances) by region and country, and the current and emerging clinical practice patterns associated with the utilization of sealants, glues, and hemostats. The report details the current clinical and technology developments in the worldwide market providing a current assessment of products in development and on the market; market size and forecast; competitor market shares; 65 competitor profiles; and an assessment of the market opportunity for current and hopeful competitors. The report provides full year (actual) 2015 market size and share data, with forecast market data to 2022, for the U.S., Europe, Asia/Pacific and Rest of World. This report details the current and projected market for sealants, glues, and hemostats, characterizing the current and future patient caseload and dollar volume market, factoring product subtype(s), application to acute versus chronic wounds, impacts on major clinical categories, and other unique segments of clinical demand. Emphasis is on the evolution of the markets as a result of technology development, market development, regulatory, reimbursement and any and all other such forces or drivers with potential to impact the relative success or failures of products on the market during the forecast period. Separate size, growth and competitor data are presented for the U.S., Europe, Asia/Pacific, and the Rest of World category.

The report also provides background data on the surgical, disease and traumatic wound patient populations targeted by current technologies and those under development, and the current clinical practices in the management of these patients, including the dynamics among the various clinical specialties or subspecialties vying for patient population and facilitating or limiting the growth of technologies.

The report establishes the current worldwide market size for major technology segments as a baseline for and projecting growth in the market through 2022. The report also assesses and projects the composition of the market as technologies gain or lose relative market performance over this period.

The report's company profiles assess leading and key emerging companies regarding their current/projected products, technologies and positions in surgical sealants, glues, and hemostats markets.

Table of Contents

EXECUTIVE SUMMARY

SECTION 1: CLINICAL NEED, CASELOAD AND PROCEDURE VOLUME

  • 1.1. Anatomy and Physiology of Tissue Repair
  • 1.2. The Skin
  • 1.3. Internal Tissues and Organ
  • 1.4. Wound Classification and Types
    • 1.4.1. Classification by Morphology and Severity
    • 1.4.2. Classification by Cause
    • 1.4.3. Surgical Wounds
  • 1.5. Caseload
    • 1.5.1. General surgeries
      • 1.5.1.1. Prostatectomy (includes TURP)
      • 1.5.1.2. Hysterectomy
      • 1.5.1.3. Plastic Surgery
      • 1.5.1.4. Appendectomy
      • 1.5.1.5. Mastectomy
      • 1.5.1.6. Inguinal Hernia Repair
      • 1.5.1.7. Drivers of General Surgeries
    • 1.5.2. Cardiovascular
      • 1.5.2.1. Congenital Heart Defects
      • 1.5.2.2. Dysfunctional Heart Valves
      • 1.5.2.3. Abdominal and Thoracic Aortic Aneurysms
      • 1.5.2.5. Drivers of Caseloads for Cardiac Surgery
    • 1.5.3. Central Nervous System
      • 1.5.3.1. Brain Tumors
      • 1.5.3.2. Cerebral Aneurysms
      • 1.5.3.3. Cerebral Arteriovenous Malformations
      • 1.5.3.4. Refractory Epilepsy
      • 1.5.3.5. Traumatic Brain Injury
      • 1.5.3.6. Epilepsy
      • 1.5.3.7. Traumatic Injury
      • 1.5.3.8. Drivers of Neurological Surgery
    • 1.5.4. Orthopedics
      • 1.5.4.1. Hip Replacement
      • 1.5.4.2. Knee Replacements
      • 1.5.4.3. Spinal Fusions
    • 1.5.5. Urology
      • 1.5.5.1. Kidney Transplant
      • 1.5.5.2. Drivers of Urological Surgery
    • 1.5.6. Dermatology
      • 1.5.6.1. Burns
      • 1.5.6.2. Drivers of Dermatological Surgery
    • 1.5.7. Pulmonary
      • 1.5.7.1. Pulmonectomies
      • 1.5.7.2. Drivers of Pulmonectomies
  • 1.6. Definitions and Roles of Medical Sealants, Adhesives and Hemostatic Products
    • 1.6.1. Definition and Role of Medical Sealants
    • 1.6.2. Definition and Role of Medical Adhesives
    • 1.6.3. Definition and Role of Hemostatic Products
  • 1.7. Natural and Biological Products
    • 1.7.1. Fibrin sealants
    • 1.7.2. Collagen-based natural sealants
    • 1.7.3. Gelatin-based Adhesives
  • 1.8. Products by Origin Material
    • 1.8.1. Human blood-based
    • 1.8.2. Animal based
  • 1.9. Synthetic and Semi-synthetic Products
    • 1.9.1. Synthetic peptides
    • 1.9.2. Polyethylene glycols
    • 1.9.3. Cyanoacrylate-based sealants
    • 1.9.4. Protein Polymeric Hydrogels
    • 1.9.5. Urethane-based Adhesives
  • 1.10. Hemostats

SECTION 2: SCIENCE, TECHNOLOGY, DEVELOPMENT, CLINICAL AND REGULATORY CHALLENGES

  • 2.1 Tissue Healing
    • 2.1.1 Hemostasis
    • 2.1.2 Proliferation and Maturation
    • 2.1.3 Factors That Affect Healing
  • 2.2 Products in Development
    • 2.2.1 History of Product Development
    • 2.2.2 Collagen and Thrombin Combination
    • 2.2.3 Polyethylene Glycol Polymer (PEG)
    • 2.2.4 Albumin Cross-Linked with Glutaraldehyde
    • 2.2.5 Delivery Systems
  • 2.3 Development Timelines
  • 2.4 Cost-Effectiveness
  • 2.5 Regulatory Challenges
    • 2.5.1 Regulatory Approvals
    • 2.5.2 Government Issues Affecting Markets for Sealants, Adhesives and Hemostats
    • 2.5.3 Mergers and Acquisitions
    • 2.5.4 Agreements and Collaborations
    • 2.5.5 New Product Launches

SECTION 3: PRODUCTS, TECHNOLOGIES, AND FORECAST OPPORTUNITIES

  • 3.1 Overview
  • 3.2 Sealants, Fibrin and Other Sealant Products
    • 3.2.1 Sealants, Fibrin and Other Sealant Competitors and Products
    • 3.2.2 Sealants, Fibrin and Other Sealant Products in Development
    • 3.2.3 Sealants, Fibrin and Other Sealant Market Analysis and Forecasts
  • 3.3 High-Strength Medical Adhesives
    • 3.3.1 High-Strength Medical Adhesives Competitors and Products
    • 3.3.2 High-Strength Medical Adhesives Products in Development
    • 3.3.3 High-Strength Medical Adhesives Market Analysis and Forecasts
  • 3.4 Hemostats
    • 3.4.1 Hemostat Competitors and Products
    • 3.4.2 Hemostat Products in Development
    • 3.4.3 Hemostat Market Analysis and Forecasts
  • 3.5 Competitive Landscape
    • 3.5.1 Market Share Concentration
    • 3.5.2 Factors for Success
    • 3.5.3 Barriers to Entry

SECTION 4: WOUND SEALANTS, ADHESIVES, AND HEMOSTATS MARKETS: GLOBAL AND REGIONAL ANALYSIS

  • 4.1 Global Market for Wound Sealants, Adhesives and Hemostats
    • 4.1.1 Global Markets for Sealants: Fibrin and Other (Thrombin, Collagen, and Gelatin-based Sealants)
      • 4.1.1.1 Fibrin-based Sealants
      • 4.1.1.2 Thrombin, Collagen, and Gelatin-based Sealants
    • 4.1.2 Global Market for High Strength Medical Glues: Biological Glues, Cyanoacrylate-based and others.
      • 4.1.2.1 Biologically-based Medical Glues
      • 4.1.2.2 Cyanoacrylate-based Medical Glues
      • 4.1.2.3 Other-based Medical Glues
    • 4.1.3 Hemostat Market Analysis and Forecast
  • 4.2 United States
  • 4.3 European Union
  • 4.4 Asia-Pacific
  • 4.5 Rest of World

SECTION 5: COMPANY PROFILES

  • 3DM, Inc. (3D-Matrix, Ltd.)
  • Actamax Surgical Materials, LLC
  • Adhesys Medical GmbH
  • Adhezion Biomedical, LLC
  • Advanced Medical Solutions Group plc/Medlogic Global
  • Arch Therapeutics, Inc.
  • Baxter International, Inc.
  • B. Braun Melsungen AG
  • Biomedica Management Corporation
  • Biom'Up SAS
  • C.R. Bard (Bard Medical, Davol)
  • Cardinal Health
  • Cellphire, Inc.
  • Celox Medical
  • Chemence Medical
  • Cohera Medical, Inc.
  • Core Scientific Creations, Ltd.
  • Covalon Technologies, Ltd.
  • Covidien Ltd.
  • CryoLife Inc.
  • CSL Behring
  • CuraMedical BV
  • Endomedix, Inc.
  • Entegrion, Inc.
  • Gecko Biomedical
  • Gelita Medical AG
  • GluStitch, Inc.
  • Grifols International, S.A.
  • Hemostasis, LLC
  • HyperBranch Medical Technology, Inc.
  • InnoTherapy, Inc.
  • Innovasa Corporation
  • Integra Lifesciences Corporation
  • Johnson & Johnson (Ethicon, Inc., Ethicon Endo-Surgery, Inc.)
  • Kuros Biosciences, Ltd.
  • LifeBond Ltd.
  • Mallinckrodt
  • Marine Polymer Technologies
  • MedTrade Products, Ltd.
  • Meyer-Haake, GmbH
  • Ocular Therapeutix, Inc.
  • OptMed, Inc.
  • Pfizer Inc.
  • Polyganics
  • Pulmonx
  • Sanofi
  • Sanyo Chemical Industries, Ltd.
  • Scion BioMedical, Inc.
  • Sealantis, Ltd.
  • Sea Run Holdings, Inc.
  • Skinstitch Corporation
  • Starch Medical, Inc.
  • Stryker
  • St. Teresa Medical, Inc.
  • Surgical Specialties Corporation
  • Takeda Pharmaceutical Company
  • The Medicines Company
  • Thrombotargets Corp.
  • Tissuemed Ltd.
  • Tricol Biomedical, Inc.
  • Vascular Solutions
  • Xcede Technologies (Dynasil)
  • Z-Medica Corporation

APPENDIX -- COMPANY DIRECTORY

List of Exhibits

  • Exhibit ES-1: Global Market for Sealants, Glues and Hemostats, 2015-2022 (USD millions)
  • Exhibit ES-2: Global Market for Wound Sealants, Glues and Hemostats, 2015-2022 (USD millions)
  • Exhibit ES-3: USA Market for Wound Sealants, Glues and Hemostats, 2015-2022 (USD millions)
  • Exhibit ES-4: European Union Market for Wound Sealants, Glues and Hemostats, 2015-2022 (USD millions)
  • Exhibit ES-5: Asia-Pacific Market for Wound Sealants, Glues and Hemostats, 2015-2022 (USD millions)
  • Exhibit ES-6: Rest of World Market for Wound Sealants, Glues and Hemostats, 2015-2022 (USD millions)
  • Exhibit ES-7: Global Markets for Sealants, Fibrin and Other Sealant Products, 2015-2022, USD Millions
  • Exhibit ES-8: Global Markets for Sealants, Fibrin and Other Sealant Products, 2015-2022, USD Millions
  • Exhibit ES-9: Regional Shares of Total Sealants, Fibrin and Other Sealant Products, 2015
  • Exhibit ES-10: Regional Shares of Total Sealants, Fibrin and Other Sealant Products, 2022
  • Exhibit ES-11: Global Competitor Revenue Market Shares, Sealants, 2015
  • Exhibit ES-12: Global Competitor Revenue Market Shares, Sealants, 2015
  • Exhibit ES-13: Global Markets for High-Strength Medical Glues, 2015-2022, USD Millions
  • Exhibit ES-14: Global Markets for High-Strength Medical Glues, 2015-2022, USD Millions
  • Exhibit ES-15: Regional Markets for High-Strength Medical Glues, 2015
  • Exhibit ES-16: Regional Markets for High-Strength Medical Glues, 2022
  • Exhibit ES-17: Global Revenue Shares by Type of High-Strength Medical Glue, 2015
  • Exhibit ES-18: Global Shares by Type of High-Strength Medical Glue, by Revenues, 2022
  • Exhibit ES-19: Global Competitor Revenue Market Shares, High-Strength Medical Glues, 2015
  • Exhibit ES-20: Global Competitor Revenue Market Shares, High-Strength Medical Glues, 2015
  • Exhibit ES-21: Global Hemostat Markets, 2015-2022, USD Millions
  • Exhibit ES-22: Global Hemostat Markets, 2015-2022, USD Millions
  • Exhibit ES-23: Global Competitor Revenue Market Shares, Hemostats, 2015
  • Exhibit ES-24: Global Competitor Market Shares, Hemostats, 2015
  • Exhibit 1-1: Skin Structure Illustrating Major Organelles and Skin Layers
  • Exhibit 1-2: Classification of Wounds by Morphology
  • Exhibit 1-3: Severity Classification of Wounds
  • Exhibit 1-4: Wound Classification by Etiology
  • Exhibit 1-5: Surgical Wound Classification
  • Exhibit 1-6: Estimated Prevalence of Various Wound Types, 2016
  • Exhibit 1-7: Projected Prostatectomy and TURP Surgical Repair Caseloads, USA, EU, Asia-Pacific and ROW, 2015-2022 (000s)
  • Exhibit 1-8: Projected Number of Hysterectomies per year, USA, EU, Asia-Pacific, 2015-2022 (000s)
  • Exhibit 1-9: Leading Plastic Surgery Procedures, USA, 2015-2022 (000s)
  • Exhibit 1-10: Leading Plastic Surgery Procedures, EU (IT, UK, FR, DE), 2015-2022 (000s)
  • Exhibit 1-11: Leading Plastic Surgery Procedures, Asia-Pacific (Japan, China, S. Korea, India, Taiwan, Thailand), 2015-2022 (000s)
  • Exhibit 1-12: Projected Totals of Most Common Plastic Surgery Procedures, USA, EU, Asia-Pacific, 2015-2022 (000s)
  • Exhibit 1-13: Projected Appendectomies in US, EU and Asia-Pacific, 2015-2022 (000s)
  • Exhibit 1-14: Projected Number of Mastectomies, USA, EU, Asia-Pacific, 2015-2022 (000s)
  • Exhibit 1-15: Projected Number of Inguinal Hernia Surgical Repairs, USA, EU, Asia-Pacific and ROW, 2015-2022 (000s)
  • Exhibit 1-16: Projected Dynamics of Congenital Heart Defect Repair Procedures, US, EU, Asia-Pacific, ROW, 2015-2022 (#000)
  • Exhibit 1-17: Projected Caseloads of Heart Valve Surgical Replacement and Repair Procedures, US, EU, Asia-Pacific, ROW, 2015-2022
  • Exhibit 1-18: Projected Caseloads & Procedures, Abdominal Aortic Aneurysms and Thoracic Aortic Aneurysms, USA, 2015-2022 (000s)
  • Exhibit 1-19: Projected Caseloads, Abdominal Aortic Aneurysms & Thoracic Aortic Aneurysms, Major Countries of European Union, 2015-2022 (000)
  • Exhibit 1-20: Projected Caseloads & Procedures, Abdominal Aortic Aneurysms and Thoracic Aortic Aneurysms, Major Countries of Asia-Pacific, 2015-2022 (000)
  • Exhibit 1-21: Projected Number of Brain Tumors in USA, EU, Asia-Pacific, 2015-2022 (000s)
  • Exhibit 1-22: Projected Number of Cerebral Aneurysms in USA, EU, Asia-Pacific, 2015-2022 (000s)
  • Exhibit 1-23: Projected Number of Cerebral Arterio-Venous Malformations in USA, EU, Asia-Pacific, 2015-2022 (000s)
  • Exhibit 1-24: Projected Caseloads of Refractory Epilepsy, USA, EU and Asia-Pacific, 2015-2022 (000s)
  • Exhibit 1-25: Projected Number of TBIs Requiring Hospitalization, USA, EU, Asia-Pacific, 2015-2022 (000s)
  • Exhibit 1-26: Projected Total Hip Arthroplasty Statistics for USA, EU and Asia-Pacific, 2015-2022 (000s)
  • Exhibit 1-27: Projected Total Knee Arthroplasty Statistics for USA, EU and Asia-Pacific, 2015-2022 (000s)
  • Exhibit 1-28: Projected Number of Spinal Fusions in USA, EU, Asia-Pacific, 2015-2022 (000s)
  • Exhibit 1-29: Projected Kidney Transplants in USA, EU, Asia-Pacific and ROW, 2015-2022 (000s)
  • Exhibit 1-30: Projected Severe Burns Requiring Hospitalization, USA, EU, 2015-2022 (000s)
  • Exhibit 1-31: Projected Pulmonectomies in US and EU, 2015-2022 (000s)
  • Exhibit 2-1: The Complex Clotting Cascade
  • Exhibit 2-2: CryoLife's BioGlue Delivery System
  • Exhibit 2-3: Selected Patents in the Sealants, Glues & Hemostats Sectors
  • Exhibit 2-4: Timescales for Development of Sealants, Glues and Hemostat Products
  • Exhibit 2-5: Selected Merger and Acquisition Activity in Sealants, Glues and Hemostats
  • Exhibit 3-1: Selected Companies and Products in the Medical Sealants, Fibrin and Other Sealants Market
  • Exhibit 3-2: Global Markets for Sealants, Fibrin and Other Sealant Products, 2015-2022, USD Millions
  • Exhibit 3-3: Global Markets for Sealants, Fibrin and Other Sealant Products, 2015-2022, USD Millions
  • Exhibit 3-4: Regional Shares of Total Sealants, Fibrin and Other Sealant Products, 2015
  • Exhibit 3-5: Regional Shares of Total Sealants, Fibrin and Other Sealant Products, 2022
  • Exhibit 3-6: Global Markets for Surgical Fibrin Sealant Products, 2015-2022, USD Millions
  • Exhibit 3-7: Global Markets for Fibrin Products, 2015-2022, USD Millions
  • Exhibit 3-8: Regional Shares of Fibrin Sealant Products, 2015
  • Exhibit 3-9: Regional Shares of Fibrin Sealant Products, 2022
  • Exhibit 3-10: Global Markets for Thrombin, Collagen & Gelatin-Based Sealants, 2015-2022, USD Millions
  • Exhibit 3-11: Global Markets for Thrombin, Collagen & Gelatin-Based Sealants, 2015-2022, USD Millions
  • Exhibit 3-12: Regional Shares for Thrombin, Collagen & Gelatin-Based Sealants, 2015
  • Exhibit 3-13: Regional Shares for Thrombin, Collagen & Gelatin-Based Sealants, 2022
  • Exhibit 3-14: Selected Medical Glue Competitors and Products
  • Exhibit 3-15: Global Markets for High-Strength Medical Glues, 2015-2022, USD Millions
  • Exhibit 3-16: Global Markets for High-Strength Medical Glues, 2015-2022, USD Millions
  • Exhibit 3-17: Regional Markets for High-Strength Medical Glues, 2015
  • Exhibit 3-18: Regional Markets for High-Strength Medical Glues, 2022
  • Exhibit 3-19: Global Revenue Shares by Type of High-Strength Medical Glue, 2015
  • Exhibit 3-20: Global Shares by Type of High-Strength Medical Glue, by Revenues, 2022
  • Exhibit 3-21: Global Markets for Biologically-Based Medical Glues, 2015-2022, USD Millions
  • Exhibit 3-22: Global Markets for Biologically-Based Medical Glues, 2015-2022, USD Millions
  • Exhibit 3-23: Regional Shares of Biologically-Based Glues, 2015
  • Exhibit 3-24: Regional Shares of Biologically-Based Glues, 2022
  • Exhibit 3-25: Global Markets for Cyanoacrylate-Based Medical Glues, 2015-2022, USD Millions
  • Exhibit 3-26: Global Markets for Cyanoacrylate-Based Medical Glues, 2015-2022, USD Millions
  • Exhibit 3-27: Regional Shares of Cyanoacrylate-Based Glues, 2015
  • Exhibit 3-28: Regional Shares of Cyanoacrylate-Based Glues, 2022
  • Exhibit 3-29: Global Markets for Other-Based Medical Glues, 2015-2022, USD Millions
  • Exhibit 3-30: Global Markets for Other-Based Medical Glues, 2015-2022, USD Millions
  • Exhibit 3-31: Regional Shares of Other-Based Medical Glues, 2022
  • Exhibit 3-32: Selected Hemostat Competitors and Products
  • Exhibit 3-33: Global Hemostat Markets, 2015-2022, USD Millions
  • Exhibit 3-34: Global Hemostat Markets, 2015-2022, USD Millions
  • Exhibit 3-35: Regional Shares of Hemostats, 2015
  • Exhibit 3-36: Regional Shares of Hemostats, 2022
  • Exhibit 3-37: Global Competitor Revenue Market Shares, Sealants, 2015
  • Exhibit 3-38: Global Competitor Revenue Market Shares, Sealants, 2015
  • Exhibit 3-39: Global Competitor Revenue Market Shares, High-Strength Medical Glues, 2015
  • Exhibit 3-40: Global Competitor Revenue Market Shares, High-Strength Medical Glues, 2015
  • Exhibit 3-41: Global Competitor Revenue Market Shares, Hemostats, 2015
  • Exhibit 3-42: Global Competitor Market Shares, Hemostats, 2015
  • Exhibit 3-43: USA Market Shares, Sealants, 2015
  • Exhibit 3-44: USA Market Shares, Sealants, 2015
  • Exhibit 3-45: USA Market Shares, Medical Glues, 2015
  • Exhibit 3-46: USA Market Shares, Medical Glues, 2015
  • Exhibit 3-47: USA Market Shares, Hemostats, 2015
  • Exhibit 3-48: USA Market Shares, Hemostats, 2015
  • Exhibit 3-49: European Union Market Shares, Sealants, 2015
  • Exhibit 3-50: European Union Market Shares, Sealants, 2015
  • Exhibit 3-51: European Union Market Shares, Medical Glues, 2015
  • Exhibit 3-52: European Union Market Shares, Medical Glues, 2015
  • Exhibit 3-53: European Union Market Shares, Hemostats, 2015
  • Exhibit 3-54: European Union Market Shares, Hemostats, 2015
  • Exhibit 3-55: Asia-Pacific Market Shares, Sealants, 2015
  • Exhibit 3-56: Asia-Pacific Market Shares, Sealants, 2015
  • Exhibit 3-57: Asia-Pacific Market Shares, Medical Glues, 2015
  • Exhibit 3-58: Asia-Pacific Market Shares, Medical Glues, 2015
  • Exhibit 3-59: Asia-Pacific Market Shares, Hemostats, 2015
  • Exhibit 3-60: Asia-Pacific Market Shares, Hemostats, 2015
  • Exhibit 3-61: Rest of World Market Shares, Sealants, 2015
  • Exhibit 3-62: Rest of World Market Shares, Sealants, 2015
  • Exhibit 3-63: Rest of World Market Shares, Medical Glues, 2015
  • Exhibit 3-64: Rest of World Market Shares, Medical Glues, 2015
  • Exhibit 3-65: Rest of World Market Shares, Hemostats, 2015
  • Exhibit 3-66: Rest of World Market Shares, Hemostats, 2015
  • Exhibit 4-1: Global Market for Wound Sealants, Glues and Hemostats, 2015-2022, (USD millions)
  • Exhibit 4-2: Global Market for Wound Sealants, Glues and Hemostats, 2015-2022 (USD millions)
  • Exhibit 4-3: Global Markets for Sealants, Fibrin and Other Sealant Products, 2015-2022, USD Millions
  • Exhibit 4-4: Global Markets for Sealants, Fibrin and Other Sealant Products, 2015-2022, USD Millions
  • Exhibit 4-5: Regional Shares of Total Sealants, Fibrin and Other Sealant Products, 2015
  • Exhibit 4-6: Regional Shares of Total Sealants, Fibrin and Other Sealant Products, 2022
  • Exhibit 4-7: Global Markets for Surgical Fibrin Sealant Products, 2015-2022, USD Millions
  • Exhibit 4-8: Global Markets for Fibrin Products, 2015-2022, USD Millions
  • Exhibit 4-9: Regional Shares of Fibrin Sealant Products, 2015
  • Exhibit 4-10: Regional Shares of Fibrin Sealant Products, 2022
  • Exhibit 4-11: Global Markets for Thrombin, Collagen & Gelatin-Based Sealants, 2015-2022, USD Millions
  • Exhibit 4-12: Global Markets for Thrombin, Collagen & Gelatin-Based Sealants, 2015-2022, USD Millions
  • Exhibit 4-13: Regional Shares for Thrombin, Collagen & Gelatin-Based Sealants, 2015
  • Exhibit 4-14: Regional Shares for Thrombin, Collagen & Gelatin-Based Sealants, 2022
  • Exhibit 4-15: Global Markets for High-Strength Medical Glues, 2015-2022, USD Millions
  • Exhibit 4-16: Global Markets for High-Strength Medical Glues, 2015-2022, USD Millions
  • Exhibit 4-17: Regional Markets for High-Strength Medical Glues, 2015
  • Exhibit 4-18: Regional Markets for High-Strength Medical Glues, 2022
  • Exhibit 4-19: Global Revenue Shares by Type of High-Strength Medical Glue, 2015
  • Exhibit 4-20: Global Shares by Type of High-Strength Medical Glue, by Revenues, 2022
  • Exhibit 4-21: Global Markets for Biologically-Based Medical Glues, 2015-2022, USD Millions
  • Exhibit 4-22: Global Markets for Biologically-Based Medical Glues, 2015-2022, USD Millions
  • Exhibit 4-23: Regional Shares of Biologically-Based Glues, 2015
  • Exhibit 4-24: Regional Shares of Biologically-Based Glues, 2022
  • Exhibit 4-25: Global Markets for Cyanoacrylate-Based Medical Glues, 2015-2022, USD Millions
  • Exhibit 4-26: Global Markets for Cyanoacrylate-Based Medical Glues, 2015-2022, USD Millions
  • Exhibit 4-27: Regional Shares of Cyanoacrylate-Based Glues, 2015
  • Exhibit 4-28: Regional Shares of Cyanoacrylate-Based Glues, 2022
  • Exhibit 4-29: Global Markets for Other-Based Medical Glues, 2015-2022, USD Millions
  • Exhibit 4-30: Global Markets for Other-Based Medical Glues, 2015-2022, USD Millions
  • Exhibit 4-31: Regional Shares of Other-Based Medical Glues, 2022
  • Exhibit 4-32: Global Hemostat Markets, 2015-2022, USD Millions
  • Exhibit 4-33: Global Hemostat Markets, 2015-2022, USD Millions
  • Exhibit 4-34: Regional Shares of Hemostats, 2015
  • Exhibit 4-35: Regional Shares of Hemostats, 2022
  • Exhibit 4-36: USA Market for Wound Sealants, Glues and Hemostats, 2015-2022 (USD millions)
  • Exhibit 4-37: USA Market for Wound Sealants, Glues and Hemostats, 2015-2022 (USD millions)
  • Exhibit 4-38: USA Market for Fibrin and Thrombin-Collagen-Gelatin Based Sealants, 2015-2022 (USD millions)
  • Exhibit 4-39: USA Market for Fibrin and Thrombin-Collagen-Gelatin-Based Sealants, 2015-2022 (USD millions)
  • Exhibit 4-40: US Markets for High-Strength Medical Glues, 2015-2022, USD Millions
  • Exhibit 4-41: US Markets for High-Strength Medical Glues, 2015-2022, USD Millions
  • Exhibit 4-42: US Markets for Hemostats, 2015-2022, USD Millions
  • Exhibit 4-43: US Markets for Hemostats, 2015-2022, USD Millions
  • Exhibit 4-44: European Union Market for Wound Sealants, Glues and Hemostats, 2015-2022 (USD millions)
  • Exhibit 4-45: European Union Market for Wound Sealants, Glues and Hemostats, 2015-2022 (USD millions)
  • Exhibit 4-46: European Union Market for Fibrin and Thrombin, Collagen & Gelatin-Based Sealants, 2015-2022 (USD millions)
  • Exhibit 4-47: European Union Market for Fibrin and Thrombin, Collagen & Gelatin-Based Sealants, 2015-2022 (USD millions)
  • Exhibit 4-48: European Union Markets for High-Strength Medical Glues, 2015-2022, USD Millions
  • Exhibit 4-49: EU Markets for High-Strength Medical Glues, 2015-2022, USD Millions
  • Exhibit 4-50: European Union Market for Hemostats, 2015-2022, USD Millions
  • Exhibit 4-51: European Union Market for Hemostats, 2015-2022, USD Millions
  • Exhibit 4-52: Asia-Pacific Market for Wound Sealants, Glues and Hemostats, 2015-2022 (USD millions)
  • Exhibit 4-53: Asia-Pacific Market for Wound Sealants, Glues and Hemostats, 2015-2022 (USD millions)
  • Exhibit 4-54: Asia-Pacific Market for Fibrin and Thrombin, Collagen and Gelatin-Based Sealants, 2015-2022 (USD millions)
  • Exhibit 4-55: Asia-Pacific Market for Fibrin and Thrombin, Collagen and Gelatin-Based Sealants, 2015-2022 (USD millions)
  • Exhibit 4-56: Asia-Pacific Market for Biological, Cyanoacrylate-Based and Other-Based High-Strength Medical Glues, 2015-2022 (USD millions)
  • Exhibit 4-57: Asia-Pacific Market for Biological, Cyanoacrylate-Based and Other-Based Medical Glues, 2015-2022 (USD millions)
  • Exhibit 4-58: Asia-Pacific Market for Hemostats, 2015-2022 (USD millions)
  • Exhibit 4-59: Asia-Pacific Market for Hemostats, 2015-2022 (USD millions)
  • Exhibit 4-60: Rest of World Market for Wound Sealants, Glues and Hemostats, 2015-2022 (USD millions)
  • Exhibit 4-61: Rest of World Market for Wound Sealants, Glues and Hemostats, 2015-2022 (USD millions)
  • Exhibit 4-62: Rest of World Market for Fibrin and Thrombin, Collagen & Gelatin-Based Sealants, 2015-2022 (USD millions)
  • Exhibit 4-63: Rest of World Market for Fibrin and Thrombin, Collagen & Gelatin-Based Sealants, 2015-2022 (USD millions)
  • Exhibit 4-64: Rest of World Market for Biological, Cyanoacrylate and Other-Based Medical Glues, 2015-2022 (USD millions)
  • Exhibit 4-65: Rest of World Market for Biological, Cyanoacrylate and Other-Based Medical Glues, 2015-2022 (USD millions)
  • Exhibit 4-66: Rest of World Market for Hemostats, 2015-2022 (USD millions)
  • Exhibit 4-67: Rest of World Market for Hemostats, 2015-2022 (USD millions)
Back to Top